Ixico inks supply agreement with LMI
15th Apr 2024 09:31
(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.
Read moreIxico warns on 2024 revenue amid contract delays
13th Mar 2024 12:25
(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.
Read moreIxico CEO to step down by end of year
12th Jan 2024 15:51
(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.
Read moreIxico full-year earnings could slightly exceed forecasts
29th Sep 2023 13:08
(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it faced a minor revenue shortfall.
Read moreIxico awarded new £2m, four-year contract
14th Jun 2023 14:17
(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of their phase 2b trial for Huntington's disease (HD).
Read moreIxico set to report first-half loss as legacy issues unwind
10th May 2023 12:36
(Sharecast News) - Medical imaging analytics specialist Ixico reported first-half revenue of £3.2m in a trading update on Wednesday, down from £3.9m in the first six months of the 2022 financial year.
Read moreIxico wins £700,000 contract with biotech company
10th Mar 2023 08:43
(Sharecast News) - Clinical research firm Ixico has won a contract to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
Read moreIxico awarded two-year MRI imaging contract
9th Dec 2022 14:21
(Sharecast News) - Neuroscience analysis technology specialist Ixico has been selected by an unnamed, "leading" global pharmaceutical company and new client, it announced on Friday, to provide MRI imaging services for an early-phase clinical trial in multiple system atrophy.
Read moreFull-year revenue set to fall for Ixico
25th Oct 2022 14:27
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico flagged full-year revenue of £8.6m in a trading update on Tuesday, down from £9.2m year-on-year.
Read moreIxico to extend work on Huntington's disease trial
14th Jun 2022 15:38
(Sharecast News) - Neuroimaging-focussed contract research organisation Ixico announced on Tuesday that an existing client has asked it to extend its breadth of services on their phase 1 and 2 trial into Huntington's disease.
Read moreIxico joins Huntington's disease research consortium
10th May 2022 15:16
(Sharecast News) - Neuroimaging contract research provider Ixico has entered a multi-party consortium for the early detection of Huntington's disease (HD), it announced on Tuesday.
Read moreIxico confident after first-half revenues fall
25th Apr 2022 10:31
(Sharecast News) - Medical imaging technology company Ixico said in a trading update on Monday that it expected first-half revenues of £3.9m, down from £4.9m year-on-year.
Read moreIxico selected for Huntington's disease detection study
21st Apr 2022 13:50
(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).
Read moreIxico wins £0.8m contract with existing US client
8th Mar 2022 15:31
(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.
Read moreIxico wins contract from new European biopharmaceutical client
8th Feb 2022 15:17
(Sharecast News) - Medical imaging analytics company Ixico has been selected to provide PET and MRI imaging services to an unnamed "leading European biopharmaceutical company" specialising in neurodegenerative conditions, it announced on Tuesday.
Read more